Patience David

Patience David is listed in filings as Chief Financial Officer at TriSalus Life Sciences, Inc.. This profile follows SEC Form 4 activity through May 18, 2026, including purchase activity. Recent filings connect the profile to TriSalus Life Sciences, Inc. (TLSI). The current snapshot covers public activity from Aug 15, 2025 to May 18, 2026. Reported amounts are shown as $17.3K to $721.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.